Search Results - Rubio-Rivas, M
-
1
Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).
Article | by Carbonell C; Marcos M; Guillén-Del-Castillo A; Rubio-Rivas M; Argibay A; Marín-Ballvé A; Rodríguez-Pintó I; Baldà-Masmiquel M; Callejas-Moraga E; Colunga D; Sáez-Comet L; González-Echávarri C; Ortego-Centeno N; Marí-Alfonso B; Vargas-Hitos JA; Todolí-Parra JA; Trapiella L; Herranz-Marín MT; Freire M; Castro-Salomó A; Perales-Fraile I; Madroñero-Vuelta AB; Sánchez-García ME; Ruiz-Muñoz M; González-García A; Sánchez-Redondo J; de-la-Red-Bellvis G; Fernández-Luque A; Muela-Molinero A; Lledó GM; Tolosa-Vilella C; Fonollosa-Pla V; Chamorro AJ; Simeón-Aznar CP; RESCLE Investigators, Autoimmune Diseases Study Group (GEAS) | Published 2022 | -
2
Nailfold videocapillaroscopy patterns in systemic sclerosis: implications for cutaneous subsets, disease features and prognostic value for survival.
Article | by Tolosa-Vilella C; Del Mar Rodero-Roldán M; Guillen-Del-Castillo A; Marín-Ballvé A; Boldova-Aguar R; Marí-Alfonso B; Feijoo-Massó C; Colunga-Argüelles D; Rubio-Rivas M; Trapiella-Martínez L; Iniesta-Arandia N; Callejas-Moraga E; García-Hernández FJ; Sáez-Comet L; González-Echávarri C; Ortego-Centeno N; Freire M; Vargas-Hitos JA; Ríos-Blanco JJ; Todolí-Parra JA; Rodríguez-Pintó I; Chamorro AJ; Pla-Salas X; Madroñero-Vuelta AB; Ruiz-Muñoz M; Fonollosa-Pla V; Simeón-Aznar CP; RESCLE Investigators | Published 2023 | -
3
Improving prediction of COVID-19 mortality using machine learning in the Spanish SEMI-COVID-19 registry
Article | by Casas Rojo, José Manuel; Ventura, PS; Antón Santos, JM; de Latierro, AO; Arévalo-Lorido, JC; Mauri, M; Rubio-Rivas, M; González Vega, R; Giner Galvañ, V; López Escobar, Alejandro | Published 2023 | -
4
Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry
Article | by Formiga, F; Rubio-Rivas, M; Mora-Lujan, JM; Escudero, SC; Martinez, RFM; Mendez-Bailon, M; Duran-del Campo, P; Perez, AR; Garcia-Sanchez, FJ; Alcala-Pedrajas, JN; Hernandez, SA; Milian, AH; Diez, AL; Sanchez, RG; Boixeda, R; Vicente, J; Cortes, B; Perez, CM; Espartero, MEG; Castro, JL; Suarez, SR; Varona, JF; Gomez-Huelgas, R; Ramos-Rincon, JM; SEMI COVID-19 SEMI COVID-19 Networ | Published 2021 | -
5
Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry.
Article | by Formiga F; Rubio-Rivas M; Mora-Luján JM; Escudero SC; Martinez RFM; Mendez-Bailón M; Campo PD; Pérez AR; García-Sánchez FJ; Alcalá-Pedrajas JN; Hernández SA; Milian AH; Díez AL; Sánchez RG; Boixeda R; Vicente J; Cortes B; Pérez CM; Espartero MEG; Castro JL; Suárez SR; Varona JF; Gomez-Huelgas R; Ramos-Rincón JM | Published 2022 | -
6
Patients with COPD hospitalized due to COVID-19 in Spain: a comparison between the first and second wave
Article | by Gómez-Antúnez M; Muiño-Míguez A; Bacete-Cebrián M; Rubio-Rivas M; Lebrón Ramos JM; de Cossío Tejido S; Peris-García J; López-Caleya JF; Casas-Rojo JM; Millán Núñez-Cortés J | Published 2023 | -
7
Remdesivir in Very Old Patients (=80 Years) Hospitalized with COVID-19: Real World Data from the SEMI-COVID-19 Registry
Article | by Ramos-Rincon, JM; Lopez-Carmona, MD; Cobos-Palacios, L; Lopez-Sampalo, A; Rubio-Rivas, M; Martin-Escalante, MD; De-Cossio-Tejido, S; Taboada-Martinez, ML; Muino-Miguez, A; Areses-Manrique, M; Martinez-Cilleros, C; Tunon-de-Almeida, C; Abella-Vazquez, L; Martinez-Gonzalez, AL; Diez-Garcia, LF; Ripper, CJ; Asensi, V; Martinez-Pascual, A; Guisado-Vasco, P; Lumbreras-Bermejo, C; Gomez-Huelgas, R | Published 2022 | -
8
Remdesivir in Very Old Patients (=80 Years) Hospitalized with COVID-19: Real World Data from the SEMI-COVID-19 Registry.
Article | by Ramos-Rincon JM; López-Carmona MD; Cobos-Palacios L; López-Sampalo A; Rubio-Rivas M; Martín-Escalante MD; de-Cossio-Tejido S; Taboada-Martínez ML; Muiño-Miguez A; Areses-Manrique M; Martinez-Cilleros C; Tuñón-de-Almeida C; Abella-Vázquez L; Martínez-Gonzalez AL; Díez-García LF; Ripper CJ; Asensi V; Martinez-Pascual A; Guisado-Vasco P; Lumbreras-Bermejo C; Gómez-Huelgas R | Published 2022 | -
9
Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry
Article | by Calderón-Parra J; Cuervas-Mons V; Moreno-Torres V; Rubio-Rivas M; Blas PA; Pinilla-Llorente B; Helguera-Amezua C; Jiménez-García N; Pesqueira-Fontan PM; Méndez-Bailón M; Artero A; Gilabert N; Ibánez-Estéllez F; Freire-Castro SJ; Lumbreras-Bermejo C; Antón-Santos JM | Published 2022 | -
10
Características clínicas y factores de riesgo de mortalidad al ingreso en pacientes con insuficiencia cardíaca hospitalizados por COVID-19 en España.
Article | by Salinas-Botrán A; Sanz-Cánovas J; Pérez-Somarriba J; Pérez-Belmonte LM; Cobos-Palacios L; Rubio-Rivas M; de-Cossío-Tejido S; Ramos-Rincón JM; Méndez-Bailón M; Gómez-Huelgas R | Published 2022 |
Search Tools:
Related Subjects
COVID-19
SARS-CoV-2
Mortality
Spain
mortality
prognosis
Coronavirus
Aged
corticosteroids
Humans
Prognosis
autoimmune diseases
heart failure
2019-nCoV
Acetylsalicylic acid
Age >= 80
C-reactive protein
Coronavirus disease 2019
Cross-infection
Elderly
Epidemiology
Glucose-lowering drug
Hospital mortality
Hospital-acquired (nosocomial) infection
Lung Diseases, Interstitial
Prognostic factors
Scleroderma, Systemic
Type 2 diabetes mellitus
antirheumatic agents
biological therapy